Functional reprogramming of regulatory T cells in the absence of Foxp3
Article 2019 en
Authors
LC
Louis‐Marie Charbonnier
YC
Ye Cui
ES
Emmanuel Stephen‐Victor
Abstract
1 min read
Regulatory T cells (T<sub>reg</sub> cells) deficient in the transcription factor Foxp3 lack suppressor function and manifest an effector T (T<sub>eff</sub>) cell-like phenotype. We demonstrate that Foxp3 deficiency dysregulates metabolic checkpoint kinase mammalian target of rapamycin (mTOR) complex 2 (mTORC2) signaling and gives rise to augmented aerobic glycolysis and oxidative phosphorylation. Specific deletion of the mTORC2 adaptor gene Rictor in Foxp3-deficient T<sub>reg</sub> cells ameliorated disease in a Foxo1 transcription factor-dependent manner. Rictor deficiency re-established a subset of T<sub>reg</sub> cell genetic circuits and suppressed the T<sub>eff</sub> cell-like glycolytic and respiratory programs, which contributed to immune dysregulation. Treatment of T<sub>reg</sub> cells from patients with FOXP3 deficiency with mTOR inhibitors similarly antagonized their T<sub>eff</sub> cell-like program and restored suppressive function. Thus, regulatory function can be re-established in Foxp3-deficient T<sub>reg</sub> cells by targeting their metabolic pathways, providing opportunities to restore tolerance in T<sub>reg</sub> cell disorders.
François Ghiringhelli, Pierre E. Puig, S. Roux, Arnaud Parcellier, E. Schmitt, Éric Solary, Guido Guido Kroemer, François Martin, Bruno Chauffert, Laurence Zitvogel
Sascha Cording, Diana Fleissner, Markus M. Heimesaat, Stefan Bereswill, Christoph Loddenkemper, Satoshi Uematsu, Akira Shizuo, Alf Hamann, Jochen Huehn
Discussion(0)
No comments yet. Be the first to comment.